Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition
- PMID: 17290303
- PMCID: PMC1784004
- DOI: 10.1172/JCI30413
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition
Abstract
Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32), encoded by PPP1R1B, is a pivotal integrator of information in dopaminoceptive neurons, regulating the response to neuroleptics, psychotomimetics, and drugs of abuse, and affecting striatal function and plasticity. Despite extensive preclinical work, there are almost no data on DARPP-32 function in humans. Here, we identify, through resequencing in 298 chromosomes, a frequent PPP1R1B haplotype predicting mRNA expression of PPP1R1B isoforms in postmortem human brain. This haplotype was associated with enhanced performance on several cognitive tests that depend on frontostriatal function. Multimodal imaging of healthy subjects revealed an impact of the haplotype on neostriatal volume, activation, and the functional connectivity of the prefrontal cortex. The haplotype was associated with the risk for schizophrenia in 1 family-based association analysis. Our convergent results identify a prefrontal-neostriatal system affected by variation in PPP1R1B and suggest that DARPP-32 plays a pivotal role in cognitive function and possibly in the pathogenesis of schizophrenia.
Figures
Similar articles
-
An association study between PPP1R1B gene and schizophrenia in the Chinese population.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1303-6. doi: 10.1016/j.pnpbp.2007.05.014. Epub 2007 Jun 7. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17618027
-
Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.Mol Psychiatry. 2014 Feb;19(2):192-9. doi: 10.1038/mp.2012.174. Epub 2013 Jan 8. Mol Psychiatry. 2014. PMID: 23295814
-
Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia.Schizophr Res. 2008 Aug;103(1-3):192-200. doi: 10.1016/j.schres.2008.05.014. Epub 2008 Jun 24. Schizophr Res. 2008. PMID: 18573638
-
[DARPP-32 in the patients with endogenous psychosis].Brain Nerve. 2007 Nov;59(11):1257-63. Brain Nerve. 2007. PMID: 18044203 Review. Japanese.
-
DARPP-32: from neurotransmission to cancer.Onco_target. 2016 Apr 5;7(14):17631-40. doi: 10.18632/onco_target.7268. Onco_target. 2016. PMID: 26872373 Free PMC article. Review.
Cited by
-
The great opportunity: Evolutionary applications to medicine and public health.Evol Appl. 2008 Feb;1(1):28-48. doi: 10.1111/j.1752-4571.2007.00006.x. Evol Appl. 2008. PMID: 25567489 Free PMC article.
-
A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.Hum Mol Genet. 2015 Oct 15;24(20):5759-74. doi: 10.1093/hmg/ddv296. Epub 2015 Jul 30. Hum Mol Genet. 2015. PMID: 26231220 Free PMC article.
-
Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.Med Mol Morphol. 2011 Dec;44(4):190-9. doi: 10.1007/s00795-010-0524-1. Epub 2011 Dec 17. Med Mol Morphol. 2011. PMID: 22179181
-
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.Alzheimers Dement. 2010 May;6(3):265-73. doi: 10.1016/j.jalz.2010.03.013. Alzheimers Dement. 2010. PMID: 20451875 Free PMC article.
-
Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms.Neuroscience. 2009 Nov 24;164(1):131-40. doi: 10.1016/j.neuroscience.2009.04.048. Epub 2009 Apr 22. Neuroscience. 2009. PMID: 19393722 Free PMC article.
References
-
- Walaas S.I., Aswad D.W., Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature. 1983;301:69–71. - PubMed
-
- Hemmings H.C., Jr., Greengard P., Tung H.Y., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 1984;310:503–505. - PubMed
-
- Svenningsson P., et al. DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 2004;44:269–296. - PubMed
-
- Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. 1998;42:707–711. - PubMed
-
- Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 1998;80:1–27. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical